Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity
Jianya Y. Huan, Roberto Meza-Romero, Jeffery L. Mooney, Yuan K. Chou, David M. Edwards, Cathleen Rich, Jason M. Link, Arthur A. Vandenbark, Dennis N. Bourdette, Hans Peter Bächinger, Gregory G. Burrows
Dive into the research topics of 'Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity'. Together they form a unique fingerprint.